VanEck Pharmaceutical ETF (NASDAQ: PPH)
Ticker | Name | Share % | |
---|---|---|---|
LLY | Eli Lilly & Co. | 11.74% | |
CO | Novo Nordisk A/S ADR | 9.41% | |
JNJ | Johnson & Johnson | 6.66% | |
MRK | Merck & Company Inc. | 6.22% | |
ABBV | Abbvie Inc Accenture Plc, Class A | 6.06% | |
LN | Astrazeneca Plc, ADR | 5.13% | |
GVMXX | State Street Navigator Securities Lending Government Money Market Portfolio | 4.71% | |
SM | Novartis Ag Sponsored Adr Sponsored Adr | 4.70% | |
COR | Cencora Inc | 4.60% | |
MCK | Mckesson Corp. | 4.54% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
PPH follows a Large Cap Value investment style.
The top holdings of PPH include: LLY (11.74%), CO (9.41%), JNJ (6.66%), MRK (6.22%), ABBV (6.06%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for PPH is currently not available.